StockData
Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc. (MRKR) stock

MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.09−0.23 (-17.42%)

Close on Nov 20, 2026Market cap $18.17MP/E –Yield –

Marker Therapeutics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Marker Therapeutics

Marker Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Marker Therapeutics figures

See a number that looks wrong?